Mark Capriani
VP of Sales
Mark brings extensive commercial leadership experience across the life sciences tools industry, with a track record of building high-performance sales organizations and driving growth at both early-stage and established companies. Prior to joining Nuclera, he held senior commercial roles at Nexcelom Bioscience, NanoTemper Technologies, Bio-Techne, and ATCC, where he led global teams, launched novel platforms, and contributed to a $260M acquisition by PerkinElmer.
At Nuclera, Mark leads the global sales organization with a focus on scaling the antibody services business and building the commercial engine to support the company's next phase of growth. He works closely with marketing, R&D, and operations to translate customer needs into commercial outcomes and ensure Nuclera's platform reaches the research teams that need it most.
Outside of work, Mark enjoys skiing, golf, hiking, and biking, and has a passion for history and the outdoors.
